medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2018, Number 3

<< Back Next >>

Arch Med Fam 2018; 20 (3)

Differences in Epicardial fat Thickness Among Normotensive, Borderline Hypertension and Hypertensive Subjects

Benitez-Maldonado DR, Narváez-Rivera JL, Guerrero GC, Lozano-Nuevo JJ, Arana Pazos KC, Rubio-Guerra AF

Language: Spanish
References: 15
Page: 113-117
PDF size: 179.90 Kb.


ABSTRACT

Objective: The purpose of this paper was to Evaluate Epicardial Fat (EFT) in subjects with hypertension, borderline hypertension (BLH) and normotension. Methods: We evaluated 120 subjects divided into 3 groups, Group H, 40 hypertensive patients, Group BLH, 40 subjects with BLH, and Group N, 40 normotensive subjects. In all of them, the epicardial fat thickness was measured as described by Iacobellis, with an Aloka alfa 6 equipment (Japan), by two cardiologists who were unaware of the clinical data. Statistical analysis was performed with ANOVA. Results: EFT was 4.55 ± 1.7 mm in H group, 4.52 ± 1.6 mm in BLH group and 3.34 ± 1.3 mm on N group. We did not find any difference in EFT between groups H and BLH (p=0.417). However, we found significantly differences in EFT between group N and groups BLH (p=0.0098), and H (p= 0.007). Conclusions: Hypertensive and BLH patients have greater EFT than normotensive subjects. Interestingly, the epicardial fat patterns in the patients with BLH resemble those from hyper-tensive patients, instead of normotensive subjects.


REFERENCES

  1. Fernández-Muñoz MJ, Basurto-Acevedo L, Córdova-Pérez N, Vázquez Martínez AL, Tepach Gutiérrez N, Vega García S, et al. La grasa epicárdica se relaciona con la visceral, el síndrome metabólico y la resistencia a la insulina en mujeres menopáusicas. Rev Esp Cardiol. 2014;67:436-41

  2. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 2015;11:363-371

  3. Laforest S, Labrecque J, Michaud A, Cianflone K, Tchernof A. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction. Crit Rev Clin Lab Sci. 2015;52:301-13.

  4. Lima-Martínez MM, Iacobellis G. Grasa epicárdica: una nueva herramienta para la evaluación del riesgo cardiometabólico. Hipertens Riesgo Vasc 2011;28:63-68.

  5. Narváez-Rivera JL, Benítez-Maldonado DR, Mondragón-Gil Nayeli S, López-Ramírez SE, Ríos Flores L, Rubio-Guerra AF, et al. Association between Epicardial Fat, Metabolic Syndrome and Obesity. J Diabetes Obes 2015;2: 1- 3.

  6. Calabuig Á, Barba J, Guembe MJ, Díez J, Berjón J, Martínez-Vila E, et al. Grasa epicárdica en la población general de mediana edad y su asociación con el síndrome metabólico. Rev Esp Cardiol (Engl Ed). 2017;70:254-260.

  7. Rubio-Guerra AF, Narváez-Rivera JL. Hipertensión arterial en el paciente obeso. Arch Med Fam 2017;19:69-80.

  8. Proyecto de Norma Oficial Mexicana PROY-NOM-030-SSA2-2017, Para la prevención, detección, diagnóstico, tratamiento y control de la hipertensión arterial sistémica. publicada en el Diario Oficial de la Federación el 19 de abril de 2017.

  9. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009;22:1311-1319.

  10. Jordan J, Birkenfeld AL. Cardiometabolic crosstalk in obesity-associated arterial hypertension. Rev Endocr Metab Disord 2016;17:19-28.

  11. Graeff DB, Foppa M, Pires JC, Vigo A, Schmidt MI, Lotufo PA, et al. Epicardial fat thickness: distribution and association with diabetes mellitus, hypertension and the metabolic syndrome in the ELSA-Brasil study. Int J Cardiovasc Imaging. 2016 ;32:563-72.

  12. Kim BJ, Kim BS, Kang JH. Echocardiographic epicardial fat thickness is associated with arterial stiffness. Int J Cardiol. 2013;167:2234-8.

  13. Ozturk MT, Ebinç FA, Okyay GU, Kutlugün AA. Epicardial Adiposity is Associated with Microalbuminuria in Patients with Essential Hypertension. Acta Cardiol Sin. 2017;33:74-80.

  14. Hachiya K, Fukuta H, Wakami K, Goto T, Tani T, Ohte N. Relation of epicardial fat to central aortic pressure and left ventricular diastolic function in patients with known or suspected coronary artery disease. Int J Cardiovasc Imaging. 2014;30:1393-8.

  15. Rubio-Guerra AF, Arana-Pazos KC, Lozano-Nuevo JJ, Morales-López H, Guerrero-García C, Vargas-Ayala G. Riesgo aumentado de trastornos metabólicos en prehipertensos. Arch Med Fam 2017;19:57-61




2020     |     www.medigraphic.com